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Introduction: Pregnancy complicated by pre-existing or 
gestational diabetes often results in macrosomic infants 
(birth weight > 4000 g) with increased body fat, but not 
increased head or brain size1. They are at increased risk 
of shoulder dystocia2, brachial plexus injury, prolonged 
labor and caesarean section. In the long term, the fetuses 
are at higher risk of becoming obese and developing Type 
2 diabetes3. We previously demonstrated MRI measures 
of fetal fat increase in a small number of diabetic 
pregnancies at late gestation4. We now extend this to a 
larger group at different gestational ages, and include 
fetal length measurements. 
Aim: To compare measurements of fetal weight, fetal 
length and fetal fat composition (made using a novel 
scanning/analysis protocol) in normal and diabetic 
pregnancies.  
Methods: Scanning: 14 diabetic and 12 control pregnant women were recruited with ethics 
approval; all gave informed consent. They were scanned twice at 22–26 weeks and 33–37 
weeks gestational age (GA), using 1.5 T Philips Achieva MRI scanner with 5-element SENSE 
cardiac coil or 4-element SENSE torso coil, depending on size. Women lay on their right 
side in the decubitus position to avoid vena caval compression. All scans were conducted 
with a specific absorption rate of <2.0 W kg-1. Two sequences were acquired in 
3 orthogonal blocks of images to allow motion effects to average out.  To measure fetal 
weight and length a Half Fourier Single Shot Turbo Spin-Echo (HASTE: 123 slices in 147 s, 
0.78×0.78×6.00 mm3 voxels, TE = 120 ms) and Balanced Fast Field Echo (bFFE, 130 slices 
in 167 s, TR = 5.8 ms, TE = 2.3 ms, flip angle = 70°, 0.78×0.78×6.00 mm3 voxels) sequences 
were acquired. To measure fetal adiposity a water suppressed fast field echo (FFE, 
12 transverse slices encompassing the whole fetus in 12.4 s, slice gap = 20 mm, 
TR = 147 ms, TE = 4.6 ms, 1.88×1.86×6.00 mm3 and FOV = 402 mm) sequence was 
acquired. Analysis: A semi-automated segmentation approach based upon pixel intensity 
was used to quantify the fat volume, taking account of noise and correcting somewhat for 
partial volume effects; this has previously proved to give reliable estimates4,5. The freehand 
mask drawn around the fetus on GIMP (2.2.13) and fat images were loaded into MATLAB 
(R2010a) to compute the intensity histogram (hj =1→N; where N is number of bins) within 
the masked region. Histograms were often bimodal with one peak corresponding to 
background noise and a second corresponding to fat voxels. The fetal fat volume (Vf) was 
calculated using: 
              and  
where X,Y,Z are the voxel dimensions, G is the slice gap and Sj is a scaling factor designed to 
take account of noise and partial volume effects.  Total fetal volume was measured on bFFE 
or HASTE images by drawing a freehand mask around the fetus using Analyze 9.0. 
Percentage fetal fat was measured from total and fat volumes. The fetal length was found 
from the sums of the length of the fetal spine (measured in two curved sections), thigh, 
lower leg and skull height (crown to base of brain stem) on the bFFE and HASTE images 
using Analyze 9.0; in order to measure the length of the spine the images were resampled obliquely. 
Results: Figure 1 shows a fat image from a diabetic pregnancy. At 22–26 weeks very little fetal fat was visible with no significant difference 
between diabetics and controls. At 33–37 weeks the data showed significant increase in fetal fat volume (p = 0.006), percentage fetal fat 
(p = 0.009) and fetal length (p = 0.017) in fetuses of diabetic mothers compared with controls (Figure 2). The total fetal volume of fetuses of 
diabetic mothers is greater than controls, but this difference was not statistically significant. The subjective intra-abdominal fat scores were 
0.13 for diabetics and 0.3 for controls at 22–26 weeks, increasing to 1.46 for diabetics and 0.9 for controls at 33–37 weeks.  
Discussion: MRI can measure the overall increase in fetal size and the increase in fetal fat fraction in diabetic pregnancies. In utero 
assessment of fetal size and fat distribution would allow clinicians to identify fetuses at risk of complicated delivery and study the effect of 
maternal diabetes on metabolic changes in the infant. 
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Figure 1: Image of a 
transverse plane through the 
fetal thorax showing fat only. 
Fetal fat surrounding thorax 
and legs can be seen.   
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Figure 2: Growth of fetal (a) Total Volume; 
(b) FAT Volume; (c) Percentage Fat; and 
(d) Length 
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